NCT00469521

Brief Summary

To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 4, 2007

Completed
Last Updated

September 10, 2007

Status Verified

September 1, 2007

First QC Date

May 2, 2007

Last Update Submit

September 5, 2007

Conditions

Tear Film Thickness

Interventions

Refresh Tears, 9582XDRUG

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal, healthy volunteers 18 years or older
  • Males or females
  • Any race or ethnic background

You may not qualify if:

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Magill Research Center Institute MUSC

Charleston, South Carolina, 29425, United States

Location

Study Officials

  • Helga Sandoval, MS, MD

    Magill Research Center Institute MUSC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

May 2, 2007

First Posted

May 4, 2007

Last Updated

September 10, 2007

Record last verified: 2007-09

Locations

US(1)